Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

Autor: Winblad, Bengt, Andreasen, Niels, Minthon, Lennart, Floesser, Annette, Imbert, Georges, Dumortier, Thomas, Maguire, R Paul, Blennow, Kaj, Lundmark, Joens, Staufenbiel, Matthias, Orgogozo, Jean-Marc, Graf, Ana
Zdroj: In The Lancet Neurology July 2012 11(7):597-604
Databáze: ScienceDirect